DDR Alterations Signal Immunotherapy Benefit in Urothelial Carcinoma – Cancer Network
|
DDR Alterations Signal Immunotherapy Benefit in Urothelial Carcinoma
Cancer Network In the new analysis, the investigators examined whether the presence of DDR mutations might be associated with similar benefit in the immunotherapy setting. They included a total of 60 patients enrolled in prospective clinical trials who were treated … |
